About this trial
This study aims to evaluate the effect of serratus posterior superior intercostal plane (SPSIP) block on postoperative pain, opioid consumption, and analgesic requirements in patients undergoing mastectomy and axillary lymph node dissection
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female patients aged 18-65 years
ASA physical status I-III
Scheduled for elective unilateral mastectomy with axillary lymph node dissection under general anesthesia
Able to understand and use the Numeric Rating Scale (NRS) for pain assessment
Disqualifiers
Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)
Coagulopathy, thrombocytopenia (<100,000/mm³), or ongoing anticoagulant/antiplatelet therapy that cannot be discontinued
Infection or skin lesion at the injection site
Planned bilateral surgery or additional major surgical procedures
Trial design
Parallel
Treatments tested in this trial
SPSIP Block With Bupivacaine
Procedure/SurgeryParticipants will receive an ultrasound-guided SPSIP block using bupivacaine.
SPSIP Block With Saline
Procedure/SurgeryParticipants will receive an ultrasound-guided SPSIP block using normal saline under identical conditions.
Treatment groups
Trial outcomes
Primary outcomes
24-hour cumulative opioid consumption
Total opioid consumption within the first 24 hours after surgery, recorded in milligrams.
Secondary outcomes
Static postoperative pain intensity at rest
Postoperative pain intensity at rest will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Dynamic postoperative pain intensity during movement
Postoperative pain intensity during movement will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Rescue analgesia requirement
Number of patients requiring rescue analgesia and total rescue analgesic consumption.
Time to first rescue analgesia
Time from the end of surgery to the first administration of rescue analgesia.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.